• Home
  • Product
  • Where to use
  • News
  • Contact

Vincent Franssen

Chief Executive Officer

HemoClear re-locates production activities to the Netherlands

13 December 2021

 

In the strategic ambition to optimize production, increase flexibility, and decrease lead times and costs, HemoClear will centralize all production activities in the Netherlands. As a promising kick-off of this project the cleanrooms were impressively fast and efficiently installed by our partner ABN Cleanroom Technology.


Watch the making of the Cleanroom

  • HemoClear joins forces with VDL in manufacturing the HemoClear autologous blood filter.

    Hemoclear joins forces with VDL HemoClear joins forces with VDL in manufacturing the HemoClear autologous blood filter. The Dutch innovation HemoClear is t

    Vincent Franssen | 26 January 2022
  • Case report Dr Bihariesingh

    New Case Report presented at BMSS2021

    As a proud sponsor, HemoClear attended the Bloodless Medicine and Surgery Society Annual Meeting. At the event Dr Rosita Bihariesingh presented a case of s

    Dion Osemwengie | 18 November 2021
  • HemoClear presents at BMSW 2021

    After celebrating Bloodless Medicine and Surgery Day on May 16, HemoClear is attending the Annual Bloodless Medicine and Surgery Week Conference. On Thursd

    Vincent Franssen | 19 November 2021
HemoClear | Red Blood Cell Filter enabling autologous blood transfusion